H.C. Wainwright raised the firm’s price target on Ocular Therapeutix (OCUL) to $15 from $14 and keeps a Buy rating on the shares ...

H.C. Wainwright raised the firm’s price target on Perpetua Resources (PPTA) to $22 from $13.25 and keeps a Buy rating on the shares ...

On Thursday, OPKO Health Inc (OPK) stock saw a modest uptick, ending the day at $1.62 which represents a slight increase of $0.02 or 1.25% from the prior close of $1.6. The stock opened at $1.58 and ...

Q3 2024 Earnings Call Transcript November 14, 2024 Emily Bodnar – H.C. Wainwright: Operator: Thank you for standing by. I ...

On Thursday, SpringWorks Therapeutics Inc (SWTX) stock saw a modest uptick, ending the day at $36.55 which represents a slight increase of $1.84 or 5.30% from the prior close of $34.71. The stock ...

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

H.C. Wainwright has downgraded Syros Pharmaceuticals (NASDAQ:SYRS) to neutral from buy, citing Tuesday’s announcement that a ...

MARA shares down as Q3 earnings miss estimates with lower revenue and adjusted loss, analysts maintain mixed views and price ...

We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at ...

Bitcoin has surged more than 26% since election day on November 5. As reported by CNBC, Mike Colonnese, an analyst at H.C.

H.C. Wainwright raised the firm’s price target on Halozyme (HALO) to $68 from $65 and keeps a Buy rating on the shares post the Q3 report. The company reported a “substantial” sales beat ...

On Wednesday, H.C. Wainwright initiated coverage on shares of FibroBiologics (NASDAQ:FBLG) with a Buy rating and a price target of $12.00. The firm focused on the potential of FibroBiologics' ...